21.06.2023 - SEATTLE, June 21, 2023 (GLOBE NEWSWIRE) - Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a focus on breast ...